Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Orexigen revises obesity drug data; shares fall
Reuters
Wednesday, April 14, 2010 - 10:44am
tags:
obesity, Orexigen, Contrave
Pozen, Teva settle patent dispute over Treximet
Yahoo/AP
Wednesday, April 14, 2010 - 10:42am
tags:
Pozen, Teva Pharmaceuticals, patents, Treximet
Time To Buy Baxter
Investopedia
Wednesday, April 14, 2010 - 9:15am
tags:
Baxter International
Teva licenses Mersana cancer treatment for $334M
Yahoo/AP
Wednesday, April 14, 2010 - 9:13am
tags:
Teva Pharmaceuticals, Mersana, cancer, liscensing
Access Pharma Readies Oral Oncology Drug for U.S. Sales
Seeking Alpha
Wednesday, April 14, 2010 - 9:09am
tags:
Access Pharmaceuticals, cancer, MuGard
Popular Anticonvulsants Raise Suicide Risks: Study
Pharmalot
Wednesday, April 14, 2010 - 9:08am
tags:
suicide, anticonvulsants, Pfizer, Neurontin, GSK, Lamictal, Novartis, Trileptal, Gabitril, Cephalon, Sanofi, Epilim, Abbott Laboratories, Depakote
CRO industry poised for recovery--followed by a shakeout
Fierce Biotech
Wednesday, April 14, 2010 - 9:05am
tags:
CROs
Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker
Seeking Alpha
Wednesday, April 14, 2010 - 9:04am
tags:
Infinity, cancer
Sanofi-Aventis: Rapidly Expanding Into Emerging Markets
Seeking Alpha
Wednesday, April 14, 2010 - 7:44am
tags:
Sanofi, emerging markets
Arqule Joins the Phase III Club
Seeking Alpha
Wednesday, April 14, 2010 - 7:44am
tags:
Arqule, Tarceva, lung cancer, clinical trials, Exelixis
Merck Hid Vioxx’s Risks From Louisiana, Official Says
Bloomberg
Wednesday, April 14, 2010 - 7:42am
tags:
Merck, Vioxx, Louisiana
FDA approves Johnson & Johnson pancreatic enzyme treatment Pancreaze
Yahoo/AP
Wednesday, April 14, 2010 - 7:40am
tags:
FDA, JNJ, Pancreaze, pancreatic cancer
Endo, Penwest settle generic Opana case with Barr
Bizjournals.com
Wednesday, April 14, 2010 - 7:39am
tags:
Penwest, Opana, generics, Endo, Barr Laboratories
Catalyst Pharma - On A High
RTT News
Tuesday, April 13, 2010 - 10:55am
tags:
Catalyst, epilepsy, Vigabatrin, Sanofi
Roche boosts position in diabetes market with buy
Reuters
Tuesday, April 13, 2010 - 10:51am
tags:
Roche, diabetes, Medingo
Xoma rallies on patents; Orexigen slides
Marketwatch
Tuesday, April 13, 2010 - 10:46am
tags:
Xoma, Orexigen, patents, Contrave
Molecular Insight shares soar after biotech reports study results for potential cancer drug
Yahoo/AP
Tuesday, April 13, 2010 - 10:45am
tags:
Molecular Insight, Onalta, cancer
Which drugs will be pharma's top 2014 blockbusters?
Fierce Pharma
Tuesday, April 13, 2010 - 10:43am
tags:
Avastin, Humira, Roche, Pfizer, Amgen, Enbrel, Lantus, Sanofi, Novo Nordisk, Novolog
Dynavax Technologies raises $44M in stock sale
Bizjournals.com
Tuesday, April 13, 2010 - 10:40am
tags:
stock offering, Dynavax
Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
Tuesday, April 13, 2010 - 10:35am
tags:
Acorda Therapeutics, AMPYRA, Cell Therapeutics, pixantrone, Pixuvri, Dendreon, Provenge, InterMune, Esbriet, Pozen, Vimovo, XenoPort, Horizant, Astellas, OSI Pharmaceuticals, Ironwood

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.